New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

For more than 12 years, Abbott's cancer diagnostics business has helped expand access to colorectal cancer screening through ...

Lynch syndrome is a symptomless genetic condition that increases the risk of developing multiple cancers. 95% of Americans ...

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening ...

Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...

Healthcare teams consider age, family history, breast density and other risk factors together to determine which screening ...

A new DNA test could help doctors determine which men with prostate cancer need more aggressive treatment and which may be spared additional therapy, offering fresh hope of reducing the treatment ...

In recognition of Breast Cancer Awareness Month, medical experts from Baystate Health discussed risk factors, screening recommendations, and treatment advances with 22News.

The global breast cancer screening and diagnostics market is projected to roughly double from $5.9 billion in 2026 to $12.15 billion by 2036, a new Research and Markets report finds, as GE HealthCare, ...

Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers. Across many disease ...

STL Capital Group, in partnership with the Care Organisation Public Enlightenment, has intensified efforts to promote breast cancer awareness and early detection through its annual awareness ...